🔗 Permalink

Inventor profile of:

Jun Qi

City:

Sharon, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2026-01-29

Top Assignees for applications by Jun Qi

The entities that hold a legal rights for patent applications filed by inventor Qi Jun:

Dana-Farber-Cancer Institute, Inc. 58 Boston, MA United States
The Children's Medical Center Corporation 3 Boston, MA United States
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 2 Boston, MA United States
Baylor College of Medicine 2 Houston, TX United States
Dana-Faber Cancer Institute, Inc. 1 Boston, MA United States
UNIVERSITY OF MASSACHUSETTS 1 Boston, MA United States

Recent patent applications by Qi Jun

Jun Qi from Sharon, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-29

US20260028367A1

Chemistry; metallurgy

DOT1L DEGRADERS AND USES THEREOF

#2 | 2025-10-30

US20250333402A1

Chemistry; metallurgy

ACETYLATION WRITER INHIBITOR DEVELOPMENT AND USES THEREOF

#3 | 2025-05-22

US20250163024A1

Chemistry; metallurgy

CHEMICAL TARGETING SWI/SNF RELATED, MATRIX ASSOCIATED, ACTIN DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 4 (SMARCA4) AND USE IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

#4 | 2025-02-27

US20250066326A1

Chemistry; metallurgy

BCL6 DEGRADERS AND USES THEREOF

#5 | 2025-01-30

US20250034126A1

Chemistry; metallurgy

CHROMOBOX PROTEIN INHIBITORS AND USES THEREOF

#6 | 2024-12-12

US20240409574A1

Chemistry; metallurgy

SMALL MOLECULES FOR DOT1L DEGRADATION AND USES THEREOF

#7 | 2024-10-17

US20240342173A1

Human necessities

CALMODULIN INHIBITORS, CHK2 INHIBITORS AND RSK INHIBITORS FOR THE TREATMENT OF RIBOSOMAL DISORDERS AND RIBOSOMAPATHIES

#8 | 2024-10-10

US20240335438A1

Human necessities

TARGETING DOT1L AND SMARCA4/2 FOR THE TREATMENT OF MLLR LEUKEMIA

#9 | 2024-05-16

US20240156800A1

Human necessities

EP300 DEGRADER AND USES THEREOF IN NEUROBLASTOMA

#10 | 2024-03-21

US20240092735A1

Chemistry; metallurgy

COMPOUNDS AND METHODS FOR TREATING CANCER

#11 | 2024-02-29

US20240067641A1

Chemistry; metallurgy

INHIBITORS OF TRIM33 AND METHODS OF USE

#12 | 2023-11-30

US20230382865A1

Chemistry; metallurgy

HISTONE DEMETHYLASE 5 INHIBITORS AND USES THEREOF

#13 | 2023-05-18

US20230149551A1

Human necessities

ARGININE METHYLTRANSFERASE 5 (PRMT5) DEGRADERS AND USES THEREOF

#14 | 2023-04-13

US20230115483A1

Chemistry; metallurgy

Small molecule inhibition of transcription factor SALL4 and uses thereof

#15 | 2023-03-30

US20230096160A1

Human necessities

COMPOUNDS, COMPOSITIONS, AND METHODS FOR PROTEIN DEGRADATION

#16 | 2022-12-08

US20220389023A1

Chemistry; metallurgy

COMPOUNDS, COMPOSITIONS, AND METHODS FOR PROTEIN DEGRADATION

#17 | 2022-11-03

US20220348563A1

Chemistry; metallurgy

KDM INHIBITORS AND USES THEREOF

#18 | 2022-08-04

US20220242872A1

Chemistry; metallurgy

E3 LIGASE BINDERS AND USES THEREOF

#19 | 2022-08-04

US20220241425A1

Human necessities

SMALL MOLECULE TARGET BROMO/ACETYL PROTEINS AND USES THEREOF

#20 | 2022-07-21

US20220227700A1

Chemistry; metallurgy

HDAC3 CATALYTIC INHIBITOR DEVELOPMENT AND USES THEREOF

#21 | 2022-04-21

US20220119416A9

Chemistry; metallurgy

BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF

#22 | 2022-02-17

US20220048942A1

Chemistry; metallurgy

DOT1L DEGRADERS AND USES THEREOF

#23 | 2022-01-13

US20220009916A1

Chemistry; metallurgy

ACETYLATION WRITER INHIBITOR DEVELOPMENT AND USES THEREOF

#24 | 2022-01-13

US20220008420A1

Human necessities

Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies

#25 | 2021-12-23

US20210393647A9

Human necessities

ACETAMIDE THIENOTRIAZOLODIAZEPINES AND USES THEREOF

#26 | 2021-07-22

US20210221826A1

Chemistry; metallurgy

BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF

#27 | 2021-07-08

US20210206779A9

Chemistry; metallurgy

CYANO THIENOTRIAZOLODIAZEPINES AND USES THEREOF

#28 | 2021-05-20

US20210147359A1

Chemistry; metallurgy

Compounds and methods for treating cancer

#29 | 2021-05-06

US20210130386A1

Chemistry; metallurgy

DOT1L degraders and uses thereof

#30 | 2021-05-06

US20210130324A1

Chemistry; metallurgy

Small molecules that block proteasome-associated ubiquitin receptor RPN13 function and uses thereof

#31 | 2021-04-01

US20210093644A1

Human necessities

Acetamide thienotriazolodiazepines and uses thereof

#32 | 2020-12-31

US20200407371A1

Chemistry; metallurgy

Small molecules for inducing selective protein degradation and uses thereof

#33 | 2020-10-08

US20200317664A1

Chemistry; metallurgy

Small molecule inhibition of transcription factor SALL4 and uses thereof

#34 | 2020-08-13

US20200255422A1

Chemistry; metallurgy

Inhibitors of TRIM33 and methods of use

#35 | 2020-06-25

US20200199150A1

Chemistry; metallurgy

Cyano thienotriazolodiazepines and uses thereof

#36 | 2020-06-04

US20200172553A9

Chemistry; metallurgy

BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF

#37 | 2020-05-14

US20200148702A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING NEOPLASIA, INFLAMMATORY DISEASE AND OTHER DISORDERS

#38 | 2020-02-06

US20200039968A9

Chemistry; metallurgy

EZH2 inhibitors and uses thereof

#39 | 2020-01-23

US20200024267A1

Chemistry; metallurgy

Chromobox protein inhibitors and uses thereof

#40 | 2020-01-09

US20200010418A1

Chemistry; metallurgy

Compounds and methods for treating cancer

#41 | 2019-10-17

US20190314374A1

Human necessities

Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies

#42 | 2019-05-09

US20190135796A1

Chemistry; metallurgy

EZH2 INHIBITORS AND USES THEREOF

#43 | 2019-05-09

US20190135790A1

Chemistry; metallurgy

Diaminopyrimidine benzenesulfone derivatives and uses thereof

#44 | 2019-02-14

US20190046541A1

Human necessities

Acetamide thienotriazolodiazepines and uses thereof

#45 | 2018-12-13

US20180354973A1

Chemistry; metallurgy

Bivalent bromodomain inhibitors and uses thereof

#46 | 2018-10-18

US20180297993A1

Chemistry; metallurgy

EZH2 inhibitors and uses thereof

#47 | 2018-10-04

US20180280522A1

Human necessities

Folate-conjugated molecules for delivery of toxic small molecule inhibitors to cancer cells and methods of use

#48 | 2018-08-23

US20180237454A1

Chemistry; metallurgy

Compositions and methods for treating neoplasia, inflammatory disease and other disorders

#49 | 2018-05-31

US20180148410A1

Chemistry; metallurgy

Compounds and methods for treating cancer

#50 | 2017-02-02

US20170029437A1

Chemistry; metallurgy

Compositions and Methods for Treating Neoplasia, Inflammatory Disease and Other Disorders

#51 | 2017-01-12

US20170008895A1

Chemistry; metallurgy

Uses of diazepane derivatives

#52 | 2016-12-01

US20160347750A1

Chemistry; metallurgy

DIHYDROPTERIDINONE DERIVATIVES AND USES THEREOF

#53 | 2016-12-01

US20160347749A1

Chemistry; metallurgy

Diazepane derivatives and uses thereof

#54 | 2016-11-17

US20160332993A1

Chemistry; metallurgy

Diaminopyrimidine benzenesulfone derivatives and uses thereof

#55 | 2016-11-03

US20160317547A1

Human necessities

Male contraceptive compositions and methods of use

#56 | 2016-06-16

US20160168154A1

Chemistry; metallurgy

Inhibitors of transcription factors and uses thereof

#57 | 2016-05-26

US20160146817A1

Physics

DOT1L probes

#58 | 2016-03-03

US20160060269A1

Chemistry; metallurgy

DOT1L inhibitors

#59 | 2016-02-04

US20160033519A1

Physics

Bromodomain binding reagents and uses thereof

#60 | 2015-06-18

US20150167062A1

Chemistry; metallurgy

Genome-wide Method of Assessing Interactions Between Chemical Entities And Their Target Molecules

#61 | 2015-06-04

US20150150885A1

Human necessities

Compositions and methods for treating neoplasia, inflammatory disease and other disorders

#62 | 2013-08-15

US20130210813A1

Human necessities

Male contraceptive compositions and methods of use

#63 | 2013-07-18

US20130184264A1

Chemistry; metallurgy

Compositions and methods for treating neoplasia, inflammatory disease and other disorders

InventorID:

345760 ⎘